RESPECT-ESUS

Objective

The purpose of this study is to compare the effectiveness and safety of oral thrombin inhibitor dabigatran etexilate versus aspirin in patients with embolic stroke of undetermined source.

Location:

Essentia Health Duluth

Disclosures:

None

For more information about a financial conflict of interest (FCOI), review the Essentia Health FCOI policy.

Last Updated: 09/08/2015

Research Study Categories

  • Adult Studies

Specialty

  • Neurology
Contact
Clinical Trials at 866-839-4128
or clinicaltrials@eirh.org